ArticleBMC surgery2025
The effect of intraoperative abdominal pressure on blood platinum levels and early complications during hyperthermic intraperitoneal chemotherapy.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectiveDuring hyperthermic intraperitoneal chemotherapy (HIPEC), high intra-abdominal pressure (IAP) increases the penetration depth of chemotherapeutic agents. Cisplatin is one of the most commonly used chemotherapeutic agents during HIPEC, and nephrotoxicity is the most common adverse effect. In this study, we aimed to evaluate the relationship between IAP increase, cisplatin levels in the blood, and early complications. MATERIALS AND
methodsDuring HIPEC, IAP was measured using a catheter placed in the intra-abdominal area. Those with IAP < 18 mmHg were classified into the low-pressure group, while those with IAP between 18 and 22 mmHg were classified into the high-pressure group. At the end of surgery, cisplatin levels were measured in the blood collected at 24 h and in urine collected during the first 24 h. Surgical data, postoperative blood levels, urine output, and 30-day morbidity and mortality outcomes were evaluated.
resultsA total of 36 patients were included in the study: 17 in the low-pressure group and 19 in the high-pressure group. Although cisplatin levels in blood samples taken at 0 and 24 h postoperatively were higher in the high-pressure group, this difference was not statistically significant. There were no differences between the groups in terms of postoperative urea and creatinine levels or the incidence of postoperative complications.
conclusionOur study demonstrated that different IAP during HIPEC do not affect the systemic circulation of cisplatin or short-term systemic complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.